Up-regulation of miR-340-5p promotes progression of thyroid cancer by inhibiting BMP4 (original) (raw)

Access this article

Log in via an institution

Subscribe and save

• Get 10 units per month
• Download Article/Chapter or eBook
• 1 Unit = 1 Article or 1 Chapter
• Cancel anytime Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

1. Siegel RL, Miller KD, Jemal A (2017) Cancer statistics, 2017. CA Cancer J Clin 67:7–30. https://doi.org/10.3322/caac.21387
   Article Google Scholar
2. Fagin JA, Wells SA Jr (2016) Biologic and clinical perspectives on thyroid cancer. N Engl J Med 375:1054–1067. https://doi.org/10.1056/NEJMra1501993
   Article CAS PubMed PubMed Central Google Scholar
3. Lai EC (2015) Two decades of miRNA biology: lessons and challenges. RNA 21:675–677. https://doi.org/10.1261/rna.051193.115
   Article CAS PubMed PubMed Central Google Scholar
4. Blenkiron C, Miska EA (2007) miRNAs in cancer: approaches, aetiology, diagnostics and therapy. Hum Mol Genet 16(Spec No 1):R106–R113. https://doi.org/10.1093/hmg/ddm056
   Article CAS PubMed Google Scholar
5. de la Chapelle A, Jazdzewski K (2011) MicroRNAs in thyroid cancer. J Clin Endocrinol Metab 96:3326–3336. https://doi.org/10.1210/jc.2011-1004
   Article CAS PubMed PubMed Central Google Scholar
6. Xiong Q, Wu S, Wang J, Zeng X, Chen J, Wei M, Guan H, Fan C, Chen L, Guo D, Sun G (2017) Hepatitis B virus promotes cancer cell migration by downregulating miR-340-5p expression to induce STAT3 overexpression. Cell Biosci 7:16. https://doi.org/10.1186/s13578-017-0144-8
   Article CAS PubMed PubMed Central Google Scholar
7. Song L, Duan P, Gan Y, Li P, Zhao C, Xu J, Zhang Z, Zhou Q (2017) MicroRNA-340-5p modulates cisplatin resistance by targeting LPAATbeta in osteosarcoma. Braz J Med Biol Res 50:e6359. https://doi.org/10.1590/1414-431X20176359
   Article CAS PubMed PubMed Central Google Scholar
8. Wozniak M, Sztiller-Sikorska M, Czyz M (2015) Diminution of miR-340-5p levels is responsible for increased expression of ABCB5 in melanoma cells under oxygen-deprived conditions. Exp Mol Pathol 99:707–716. https://doi.org/10.1016/j.yexmp.2015.11.014
   Article CAS PubMed Google Scholar
9. Zhang Q, Lou Y, Zhang J, Fu Q, Wei T, Sun X, Chen Q, Yang J, Bai X, Liang T (2017) Hypoxia-inducible factor-2alpha promotes tumor progression and has crosstalk with Wnt/beta-catenin signaling in pancreatic cancer. Mol Cancer 16:119. https://doi.org/10.1186/s12943-017-0689-5
   Article PubMed PubMed Central Google Scholar
10. Yoshida T, Song L, Bai Y, Kinose F, Li J, Ohaegbulam KC, Munoz-Antonia T, Qu X, Eschrich S, Uramoto H, Tanaka F, Nasarre P, Gemmill RM, Roche J, Drabkin HA, Haura EB (2016) ZEB1 mediates acquired resistance to the epidermal growth factor receptor-tyrosine kinase inhibitors in non-small cell lung cancer. PLoS ONE 11:e0147344. https://doi.org/10.1371/journal.pone.0147344
    Article CAS PubMed PubMed Central Google Scholar
11. Gao H, Teng C, Huang W, Peng J, Wang C (2015) SOX2 promotes the epithelial to mesenchymal transition of esophageal squamous cells by modulating slug expression through the activation of STAT3/HIF-alpha signaling. Int J Mol Sci 16:21643–21657. https://doi.org/10.3390/ijms160921643
    Article CAS PubMed PubMed Central Google Scholar
12. Lan L, Luo Y, Cui D, Shi BY, Deng W, Huo LL, Chen HL, Zhang GY, Deng LL (2013) Epithelial-mesenchymal transition triggers cancer stem cell generation in human thyroid cancer cells. Int J Oncol 43:113–120. https://doi.org/10.3892/ijo.2013.1913
    Article CAS PubMed Google Scholar
13. Lopez JP, Wang-Rodriguez J, Chang C, Chen JS, Pardo FS, Aguilera J, Ongkeko WM (2007) Gefitinib inhibition of drug resistance to doxorubicin by inactivating ABCG2 in thyroid cancer cell lines. Arch Otolaryngol Head Neck Surg 133:1022–1027. https://doi.org/10.1001/archotol.133.10.1022
    Article PubMed Google Scholar
14. Mitra A, Mishra L, Li S (2015) EMT, CTCs and CSCs in tumor relapse and drug-resistance. Oncotarget 6:10697–10711. https://doi.org/10.18632/oncotarget.4037
    Article PubMed PubMed Central Google Scholar
15. Zhou Y, Tong L, Chu X, Deng F, Tang J, Tang Y, Dai Y (2017) The adenosine A1 receptor antagonist DPCPX inhibits tumor progression via the ERK/JNK pathway in renal cell carcinoma. Cell Physiol Biochem 43:733–742. https://doi.org/10.1159/000481557
    Article CAS PubMed Google Scholar
16. Zhu J, Wang FL, Wang HB, Dong N, Zhu XM, Wu Y, Wang YT, Yao YM (2017) TNF-alpha mRNA is negatively regulated by microRNA-181a-5p in maturation of dendritic cells induced by high mobility group box-1 protein. Sci Rep 7:12239. https://doi.org/10.1038/s41598-017-12492-3
    Article CAS PubMed PubMed Central Google Scholar
17. Czajka AA, Wojcicka A, Kubiak A, Kotlarek M, Bakula-Zalewska E, Koperski L, Wiechno W, Jazdzewski K (2016) Family of microRNA-146 regulates RARbeta in papillary thyroid carcinoma. PLoS ONE 11:e0151968. https://doi.org/10.1371/journal.pone.0151968
    Article CAS PubMed PubMed Central Google Scholar
18. Ampuja M, Jokimaki R, Juuti-Uusitalo K, Rodriguez-Martinez A, Alarmo EL, Kallioniemi A (2013) BMP4 inhibits the proliferation of breast cancer cells and induces an MMP-dependent migratory phenotype in MDA-MB-231 cells in 3D environment. BMC Cancer 13:429. https://doi.org/10.1186/1471-2407-13-429
    Article CAS PubMed PubMed Central Google Scholar
19. Fang WT, Fan CC, Li SM, Jang TH, Lin HP, Shih NY, Chen CH, Wang TY, Huang SF, Lee AY, Liu YL, Tsai FY, Huang CT, Yang SJ, Yen LJ, Chuu CP, Chen CY, Hsiung CA, Chang JY, Wang LH, Chang IS, Jiang SS (2014) Downregulation of a putative tumor suppressor BMP4 by SOX2 promotes growth of lung squamous cell carcinoma. Int J Cancer 135:809–819. https://doi.org/10.1002/ijc.28734
    Article CAS PubMed Google Scholar
20. Shirai YT, Ehata S, Yashiro M, Yanagihara K, Hirakawa K, Miyazono K (2011) Bone morphogenetic protein-2 and -4 play tumor suppressive roles in human diffuse-type gastric carcinoma. Am J Pathol 179:2920–2930. https://doi.org/10.1016/j.ajpath.2011.08.022
    Article CAS PubMed PubMed Central Google Scholar
21. Reddy KB (2015) MicroRNA (miRNA) in cancer. Cancer Cell Int 15:38. https://doi.org/10.1186/s12935-015-0185-1
    Article CAS PubMed PubMed Central Google Scholar
22. Duerr EM, Mizukami Y, Moriichi K, Gala M, Jo WS, Kikuchi H, Xavier RJ, Chung DC (2012) Oncogenic KRAS regulates BMP4 expression in colon cancer cell lines. Am J Physiol Gastrointest Liver Physiol 302:G1223–G1230. https://doi.org/10.1152/ajpgi.00047.2011
    Article CAS PubMed PubMed Central Google Scholar
23. Meng X, Zhu P, Li N, Hu J, Wang S, Pang S, Wang J (2017) Expression of BMP-4 in papillary thyroid carcinoma and its correlation with tumor invasion and progression. Pathol Res Pract 213:359–363. https://doi.org/10.1016/j.prp.2017.01.008
    Article CAS PubMed Google Scholar
24. Rupaimoole R, Slack FJ (2017) MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov 16:203–222. https://doi.org/10.1038/nrd.2016.246
    Article CAS PubMed Google Scholar
25. Bai XL, Zhang Q, Ye LY, Liang F, Sun X, Chen Y, Hu QD, Fu QH, Su W, Chen Z, Zhuang ZP, Liang TB (2015) Myocyte enhancer factor 2C regulation of hepatocellular carcinoma via vascular endothelial growth factor and Wnt/beta-catenin signaling. Oncogene 34:4089–4097. https://doi.org/10.1038/onc.2014.337
    Article CAS PubMed Google Scholar

Download references